На главную
Результаты поиска “U.S. Pharmaceutical Sales Statistics” за 2018
The Fines That Pharmaceutical Companies Have Paid with Gwen Olsen
 
06:00
On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned firsthand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. Connect with The Real Truth About Health http://www.therealtruthabouthealth.com/ https://www.facebook.com/The-Real-Truth-About-Health-467500836655781/ https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO's. Fighting to stop climate change and extinction.
Просмотров: 308 The Real Truth About Health
Drug companies turn to lobbying amid state opioid lawsuits
 
03:49
More than 30 state attorneys general are investigating and negotiating with the pharmaceutical industry to reach a settlement over the opioid crisis, but a number of attorneys general have lost patience and have left the group to sue opioid manufacturers directly. Julianna Goldman reports. Subscribe to the "CBS This Morning" Channel HERE: http://bit.ly/1Q0v2hE Watch "CBS This Morning" HERE: http://bit.ly/1T88yAR Watch the latest installment of "Note to Self," only on "CBS This Morning," HERE: http://cbsn.ws/1Sh8XlB Follow "CBS This Morning" on Instagram HERE: http://bit.ly/1Q7NGnY Like "CBS This Morning" on Facebook HERE: http://on.fb.me/1LhtdvI Follow "CBS This Morning" on Twitter HERE: http://bit.ly/1Xj5W3p Follow "CBS This Morning" on Google+ HERE: http://bit.ly/1SIM4I8 Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8 Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B Delivered by Norah O’Donnell and Gayle King, "CBS This Morning" offers a thoughtful, substantive and insightful source of news and information to a daily audience of 3 million viewers. The Emmy Award-winning broadcast presents a mix of daily news, coverage of developing stories of national and global significance, and interviews with leading figures in politics, business and entertainment. Check local listings for "CBS This Morning" broadcast times.
Просмотров: 1235 CBS This Morning
The USA Has 5% Of The Worlds Population And Uses 70% Of The World's Pharmaceuticals
 
10:47
On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen  offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned firsthand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. Connect with The Real Truth About Health http://www.therealtruthabouthealth.com/ https://www.facebook.com/The-Real-Truth-About-Health-467500836655781/ https://twitter.com/RTAHealth Passionate believers in whole food plant based diets, no chemicals, minimal pharmaceutical drugs, no GMO's. Fighting to stop climate change and extinction.
Просмотров: 607 The Real Truth About Health
Global Antidepressant Drugs Market: Opportunities and Forecasts (2018-2023)
 
02:01
Globally, the market for antidepressant drugs mask has been growing at a swift pace on the back of rising prevalence mental disorders, rising healthcare awareness and rising disposable incomes. Apart from these factors, rising healthcare facilities, increasing number of psychiatrist as well as surging number of hospital and clinics and burgeoning growth in Asia Pacific market is impelling growth in the market. A comprehensive research report that analyses the antidepressant drugs market and the drugs market by Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents, the report also assesses the sales of antidepressant drugs by sales channels - Hospital & Clinics, Retail Pharmacies, Others. A research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market By Region (North America, Europe, Asia Pacific and Rest of the world) and By Country (U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia) for the historical period of 2013-2017 and forecast period of 2018-2023. According to Azoth Analytics research report “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)”, the global market is projected to display a robust growth represented by a CAGR of 3.12% during 2018 – 2023. The Selective Serotonin Reuptake Inhibitors (SSRIs) drug class has witnessed growth at a noteworthy rate over the past few years and in the forecast period on account of rising health awareness related to mental disorders particularly in developing countries including China, India, etc., rising healthcare expenditure as well as rising disposable incomes. Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs in 2017. The report titled “Global Antidepressant Drugs Market – Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (APAC, N. America, Europe, RoW), By Country (US, Canada, UK, Germany, China, India, Japan, Brazil, South Arabia)” has covered and analysed the potential of Global Antidepressant Drugs Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressant drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antidepressant Drugs Market: Analysis By Drugs Class (Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics and Novel Agents), By Sales Channels (Hospital & Clinics, Retail Pharmacies, Others) for the Regions (North America, Europe, Asia Pacific and Rest of the world) and for Countries (U.S., Canada , Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia). http://azothanalytics.com/report/healthcare-pharma/global-antidepressant-drugs-market-analysis-by-drugs-class-by-sales-channel-by-region-by-country-opportunities-and-forecasts-2018-2023-r15150 Contact us at: Azoth Analytics Pvt. Ltd. Tel: +91 120 4298 235 Email: azothanalytics7@gmail.com Site: http://azothanalytics.com/
Просмотров: 3 Azoth Analytics
What is EPSYCHOLOGY? What does EPSYCHOLOGY mean? EPSYCHOLOGY meaning, definition & explanation
 
03:39
What is EPSYCHOLOGY? What does EPSYCHOLOGY mean? EPSYCHOLOGY meaning - EPSYCHOLOGY definition - EPSYCHOLOGY explanation. Source: Wikipedia.org article, adapted under https://creativecommons.org/licenses/by-sa/3.0/ license. SUBSCRIBE to our Google Earth flights channel - https://www.youtube.com/channel/UC6UuCPh7GrXznZi0Hz2YQnQ Epsychology is a form of psychological intervention delivered via information and communication technology. epsychology interventions have most commonly been applied in areas of health; examples are depression, adherence to medication, and smoking cessation. Future applications of epsychology interventions are likely to become increasingly more common in information, organization, and management sciences (e.g. organizational change, conflict management and negotiation skills). Recently, several meta-analyses have documented the effects of epsychology interventions. In general, it appears that intensive theory-based interventions that include multiple behaviour change techniques and modes of delivery (e.g. mobile phones and the Internet) are the most effective. More specifically, interventions based on the theory of planned behaviour and cognitive-behavioural therapy seem to provide the most promising results. These findings should, however, be interpreted with caution as many research articles fail to report the theoretical underpinnings of epsychology interventions adequately. Lifestyle and non-communicable diseases, such as excessive alcohol consumption, depression, and physical inactivity, are the leading causes of morbidity and premature mortality. Thus, there is a great potential for utilizing epsychology to reach out and deliver prevention and treatment to the public by means of information technology. Information technology has a high scalability and given the usage and population statistics on, for example, Internet technology, researchers argue that we simply cannot afford to ignore information technology as a viable approach to public health. Among the first companies to take advantage of the new technological opportunities combined with state-of-the-art psychological research were Health Media in the US (later acquired by Johnson & Johnson) and the privately held Changetech AS in Norway. Epsychology interventions are considered a supplement to existing treatments rather than a substitute, although such interventions can be used as a stand-alone treatment given that they are more cost-effective than standard treatment. Pharmaceutical companies Janssen-Cilag and Novartis were also early out with patient-support programs that came with the patients' medication. The purpose in such programs is primarily to help patients take their medication as prescribed. A lack of medical compliance is a serious health problem even among patients diagnosed with severe and potentially fatal diseases such as cancer or HIV/AIDS. In fact, in one study about 70% of hospital visits for adverse drug reactions were caused by inadequate medical compliance. Although patient-support programs may lack in theoretical orientation, it is clear that they try to help patients manage an inherent psychological problem.
Просмотров: 4 The Audiopedia
Katherine Eban: The Helpless U.S. in the Global Pervasiveness of Fraudulent Drugs on The Open Mind
 
27:38
Investigative reporter Katherine Eban joins us on The Open Mind to shed light on her findings surrounding pharmaceutical counterfeiting. Eban uncovered the comprehensive picture of how under-policed generic companies operate for Fortune Magazine. As she writes, “It’s not a tale of cutting corners or lax manufacturing practices, but one of outright fraud in which the company knowingly sells substandard drugs around the world including in the US, while working to deceive regulators.” Watch on PBS: http://www.pbs.org/show/open-mind/ Watch on Thirteen.org: https://www.thirteen.org/openmind/ Follow The Open Mind on Twitter: https://twitter.com/OpenMindTV Follow Katherine Eban on Twitter: https://twitter.com/KatherineEban Follow Alexander Heffner on Twitter: https://twitter.com/heffnera In this episode of The Open Mind, we discuss how the high cost of medication in the United States has led us into the arms of foreign powers to produce low-cost generic drugs. Big Pharma companies have become experts in how to fraudulently market drugs and alter data in manufacturing labs. Yet, top executives are not put in jail. The FDA, originally set up as a domestic agency, finds itself tasked with becoming a global policeman of foreign manufacturing plants. Ill-equipped for this responsibility, overseas manufacturing plants often end up fooling the FDA to gain approval for drugs that don’t actually work. While the impact on patients will likely never be known, it’s clear that millions of people worldwide got medicine of dubious quality. What do we need to do to start tackling worldwide drug counterfeiting? Eban argues that the United States can start by regulating drug prices to take some of the profit and heat out of the pharma marketplace, releasing us from the arms of low-cost drug makers in developing countries like India and China. Bringing drug production back to the United States can be pricey, but Eban believes we are a couple of scandals away from widespread awareness in terms of drug pricing. Eban suggests that we need a consumer revolution to spark change, and stresses the importance of remaining persistent throughout our unusual news cycles, holding onto and pushing through important issues.
Просмотров: 71 The Open Mind
Opium Drug Abuse: Statistics
 
00:42
-- Created using PowToon -- Free sign up at http://www.powtoon.com/youtube/ -- Create animated videos and animated presentations for free. PowToon is a free tool that allows you to develop cool animated clips and animated presentations for your website, office meeting, sales pitch, nonprofit fundraiser, product launch, video resume, or anything else you could use an animated explainer video. PowToon's animation templates help you create animated presentations and animated explainer videos from scratch. Anyone can produce awesome animations quickly with PowToon, without the cost or hassle other professional animation services require.
Просмотров: 7 Adeline Addy
Warehouse Management System [REAL LIFE EXAMPLE] - "Went from processing 30 orders a day to 100"
 
05:40
Blue Link customer, Peter from Kroeger Inc., shares how the company was able to go from processing 30 orders a day to 100 orders a day with Blue Link's WMS! From improving product visibility to integrating with shipping carriers and scanning devices...a WMS can have countless benefits to your small business processes. Ready to improve your business processes? www.bluelinkerp.com Follow us on social! Facebook: https://www.facebook.com/BlueLinkERP/ Twitter: https://twitter.com/BlueLinkERP LinkedIn: https://ca.linkedin.com/company/blue-link-associates-limited Google +: https://plus.google.com/+BlueLinkERP About Blue Link ERP Software: Blue Link ERP provides integrated inventory and accounting ERP software for small-medium size businesses and is best suited for those in the wholesale and distribution industry. As an all-in-one system, we help businesses streamline and automate their processes by providing inventory management, accounting, order entry, warehouse management, and customer relationship management. In addition, Blue Link provides various optional components such as eCommerce integration, barcode scanning, POS, lot tracking and landed cost tracking, and can be customized in order to meet the specific needs of clients. Blue Link ERP is offered as both a hosted (cloud-based) and on-premises solution.
Просмотров: 98 Blue Link Associates Limited
Greenville County sues pharmaceutical companies
 
03:05
Greenville County sues pharmaceutical companies.
Просмотров: 35 WSPA 7News
3 STOCKS TO BUY APRIL 2018
 
09:41
3 Stocks to Buy in April 2018 is a popular series on this channel. I cover stocks to watch, buy, invest in April 2018! These are 3 stocks you can buy today, and hold forever on the dip as they are currently presenting great opportunities for entries. The 3 picks for this month are Nvidia Stock, Facebook Stock, and Home Depot Stock. All 3 of these companies have had a great 2017, and have recently been experiencing some turbulence but I believe they will make a good recovery in 2018. 1) Nvidia Stock Analysis NVDA These guys are just a profit machine and growth machine and they keep posting outstanding numbers and show no signs of slowing down. The last month or so as the market has been a bit weak and volatile, NVDA has kind stood its ground. Everytime it sells off, buyers come back in to push it higher. This stock is really outperforming the market right now, and is showing similar strength as AMZN and NFLX as well. In march, we had 2 analysts come out and reiterate their view on NVDA this month. Both have targets that are a lot higher than the current share price and it's clear analysts are also very bullish on NVDA's future. If you want to see my technical analysis and view on Nvidia, check out the video. 2) Facebook Stock Analysis FB You guys already know my stance on FB - this is a stock I personally hold in my long term portfolio, and it's a company that just keeps growing. They own FB, Insta, and WHatsapp, and they have over 2B users on these platforms. Celebs are switching from Snap to Insta, which is where I think FB will be seeing a lot of $ coming in from. The selloff imo was unwarranted - I gave my reasoning in this video so check it out if you're unsure. I believe FB will recover this year - but April in a great time to scoop up more shares in this company. It might be a slower recovery than we're used to, but as long as their earnings and growth continue, it should be back to ATH this year. In march there was only 1 analyst who came out and reiterated their stance on Facebook. If you want to see my technical analysis and view on Nvidia, check out the video. 3) Home Depot Stock Analysis HD HD - of course a home improvement store, the largest in this space in North America - and their only true competitor is Lowes - who is far behind. Morgan Stanley said the recent weakness has created a "compelling entry point" for investors. You shouldn't believe what these Analysts say, but you should pay attention to the general sentiment. Nothing has fundamentally changed in HD and they are still strong, and MS recognizes that. There are fears out there that interest rate hikes may affect home sales and renovation sales - but this is something we'll have to wait and see about. We did have hikes in the past, and home sales just kept rising QoQ, so if the last few years tells us anything, it's that people want to buy houses! In March, Loop Capital initiated coverage on HD. If you want to see my technical analysis and view on Nvidia, check out the video. Thank you for watching! Don't forget to LIKE, COMMENT and SUBSCRIBE if you haven't done so already to support the channel - it means a lot to me! Let me know what videos you would like me to cover in the future. Either way, remember to invest positively. Peace! Disclaimer: None of the stocks, options, or securities that I discuss should be taken as advice or recommendations to buy/sell/hold as I am not a financial adviser. The views and information presented in these videos is strictly for educational purposes and I will not be held liable for your gains or losses incurred due to trading, investing, or getting involved in the stock market. Follow me on Twitter: https://goo.gl/w4xsnl Follow me on Instagram: https://goo.gl/fW5rYn Equipment used for videos: Microphone: http://amzn.to/2zVpWGz Lighting Kit: http://amzn.to/2EVbL8t Camera: http://amzn.to/2HPaqgT Laptop for Editing: http://amzn.to/2EUbORQ
My #1 Favorite Dividend Stock of All Time (If I Could Only Own 1 Dividend Stock)
 
25:47
Several subscribers recently asked about my favorite dividend growth stock of all time. Specifically, they asked which dividend stock I would own if I had to place all of my investment funds in one single stock. My answer is quite simple, as Johnson & Johnson (ticker: JNJ) is already the largest position in my portfolio. Today's video explains why Johnson & Johnson is my favorite stock for dividends, complete with fundamental analysis. I get started with some high level thoughts. Why do I like this stock so much? It really comes down to some high level concepts including: * Predictability (and stability) * Incredible margins (gross profit and operating) * Population trends (aging US population and growing global population) * More! Next, I dive into my Johnson & Johnson fundamental stock analysis. Specifically, I discuss concepts including: * Revenue Growth: I really enjoy how revenue is up 25% comparing 2007 and 2017. I also like how revenue tends to grow predictably on a year-by-year basis. It's like clockwork. * US versus international mix. International sales are getting close to representing 50% of this company's mix. * Incredible Margins: Gross profit is at 66.8% (wow!) and operating profit is at 23% (both from the 2017 annual report). * Dividend growth: I invest for passive income and cash flow! I need to buy companies to put cash in my pocket, cash that can be used to pay the bills. Johson & Johnson is a great example, as they've raised their dividend over 105% comparing 2017 to 2007. Despite stellar fundamentals, it looks like Johnson & Johnson has a PE ratio in the 22.94 range right now (possibly a bit lower). I backed into this number, since EPS is thrown off by one-time tax items. Certainly, the stock is priced for perfection, but it always seems to be! While I'm not buying this stock in 2018 (other than reinvesting dividends), I do want to buy more. I'm waiting for a correction, although I never expect a big one with this stock. Of course, there are a few risk factors with JNJ. I close out discussing those potential risks: * Patent expiration and the need to always innovate in their pharmaceutical division. * Overall pricing of their products (the US health care system is broken). Want to learn more about my dividend growth investing strategies? Here are a few popular videos on how I would hypnotically invest different sums of money. Getting started with $1,000: https://www.youtube.com/watch?v=Iijz-5vGSh0 Getting started with $5,000 in dividend stocks: https://www.youtube.com/watch?v=5Bp0TzQKRr0 Getting started investing with $10,000: https://www.youtube.com/watch?v=4i_3KAY1ZMo Going big with $25,000 in dividend stocks: https://www.youtube.com/watch?v=CGrf5He8ieU Investing $50,000 in income-producing securities: https://www.youtube.com/watch?v=ishEcrSTK-c Want to connect on Instagram? Please make sure to say hi! https://www.instagram.com/ianlopuch/ Disclosure: I am long Johnson & Johnson (JNJ). I own this stock in my portfolio. Disclaimer: I'm not a licensed investment advisor, and today's video is just for entertainment and fun. This video is NOT investment advice. Also, I'm not a tax advisor and today's video is NOT tax advice. Please talk to your licensed investment advisor before making any financial decisions. All content on my YouTube channel is (c) Copyright IJL Productions LLC.
Просмотров: 6780 ppcian
FBP 151: Crushing It with Messenger Chat Bot Marketing Expert Niel Reichl
 
01:22:04
A combination of relentless drive and plenty of hard work turned unfortunate events into opportunities for our FBP 151 guest. This guy with an easy demeanor and bright outlook has also proved himself to be resilient and a fast learner. In 3 years, Neil Reichl has turned from a pharmaceutical sales rep to a ChatBot marketing expert. All the long drives that he made while listening to podcasts when he was still a sales rep turned out to be the training ground for his digital marketing and freelancing career. WHY CHATBOT MARKETING? An early adopter of ChatBot marketing, Neil recognized the need for a more effective way of getting leads and engaging with old both old and potential customers. With an even tougher competition now as all types of media are clamoring for a person’s already short attention span, how does a business get their voice heard loud and clear? With email marketing effectivity slowly dropping (25% open rate, 3% CTR), Neil saw how more people, regardless of age or status, are now more likely to use Facebook Messenger as their main means of communication. It is not surprising that statistics for Facebook Messenger Marketing campaigns show an 89% open rate with a 50-60% CTR. For instance, the reach can be greater too as people who may not follow or “like” your page can still send you a message and contact you on Facebook. Are you as interested as I am now? I too believe that ChatBot marketing is the next big thing so I signed up for Neil’s ChatBot marketing premium course to learn more about it. If you want to see a ChatBot in action, watch the FBP 151 video to see a demo of how a ChatBot can bring in more leads and convert fans into paying customers. KEY HIGHLIGHTS FBP 151 comes with loads of useful tips from Neil. Also, you will get the chance to see us in our formal wear! QUOTES Neil on how to effectively use ChatBots: “Courtesy should always be your first step” Marv on taking new challenges from clients: “Say yes and learn it.” Neil on avoiding analysis paralysis: “Take action!” LINKS - See a ChatBot in action here: http://bit.ly/chatbotMarv - ManyChat.com - Do you want to get more tips for fellow freelancers? Join us on Facebook and connect with hundreds of Filipino freelancers! https://www.freelanceblenders.com
Просмотров: 41 FreelanceBlend
MNK - Mallinckrodt Public Limited Company MNK buy or sell Buffett read basic
 
01:20
Buffett said: He saw all the stock earnings I think the final value of the investment does not need to see numbers only need to figure out what the business is doing with the most basic information to determine The following is my finishing out of the super basic Hoping to help you get the most out of all stocks with the fastest time maybe we can leave message to discuss like... 1. ask your question 2. Master! Buy and sell? 3. Share your experience for this stock
Просмотров: 7 Buffett Info
Hack To Improve Conference Call Stamina And Effectiveness
 
05:03
Hack To Improve Call Stamina And Effectiveness This is a small hack that can be used to improve conference call stamina and effectiveness. In the corporate world we are constantly inundated with meeting after meeting and call after call. Are all these meetings necessary? Are all these meetings effective? How can we conduct a better meeting, so that only what is necessary is being discussed and only having meetings when necessary, not everyday just because thats how it has always been. Don't forget to Subscribe for new content! Email: eliteclinicalgroup@gmail.com Podcast: https://anchor.fm/clinical-research-podcast Steemit: https://steemit.com/@ecrgmedia Watch: » Industry News: https://goo.gl/fNXpQ5 » All Videos: https://goo.gl/87XEFW » Interview Recaps: https://goo.gl/wJsk6W » Glassdoor Reviews: https://goo.gl/AbQzqe We do: » Insider Interviews » Resume Reviews » Question and Answer » Discuss all things Clinical Research » News and Product Reviews » Education This is a small hack that can be used to improve conference call stamina and effectiveness. In the corporate world we are constantly inundated with meeting after meeting and call after call. Are all these meetings necessary? Are all these meetings effective? How can we conduct a better meeting, so that only what is necessary is being discussed and only having meetings when necessary, not everyday just because thats how it has always been. ------------------------------------------------------------------------------------------------------------ Elite Clinical Research Group or ECRG for short is a content creating conglomerate that offers many services to individuals in the clinical research and pharmaceutical space. We always keep our "Why" of improving patients lives in mind with everything we do and are always looking to partner with people that are of like mind. Clinical Research is one of the hottest fields in the world right now and thousands of college graduates, masters candidates and phd graduates are looking to enter the clinical research world. Reach out by comment or email if we can help in any way. -~-~~-~~~-~~-~- Please watch: "Face to Face Workplace Etiquette - Clinical Trials Industry" https://www.youtube.com/watch?v=i_uK7hf59CM -~-~~-~~~-~~-~-
Просмотров: 11 Elite Clinical Research
8 Examples That Prove Big Pharma Cares More About Profits Than People
 
08:15
To your health, body and spirit - 8 Examples That Prove Big Pharma Cares More About Profits Than People The alternative health media has published many scathing exposés revealing some of the dirty tricks used by Big Pharma to maintain or increase its profit margin. Quite simply, each and every exposé shows capitalism at its ugliest, and as a consequence of their actions, patients affected may end up broke, permanently sick, sicker, or even dead. How low will Big Pharma stoop in its lust for profits? As an insight, and with a view towards protecting yourself not becoming a victim of corporate greed, here are 8 examples to show how Big Pharma cares more about profits than people. 1. Protecting self-interests Irrespective of high efficacy, the selling of cheap, natural, non-toxic alternative remedies are regarded by Big Pharma as a threat to their profit margins. With help from the authoritative muscle of the FDA and the DEA, Big Pharma makes sure that these alternative remedies are criminalized to protect their self-interests. Read More/Article Source Link/Credit(FAIR USE): https://wakeup-world.com/2018/02/23/8-examples-that-prove-big-pharma-cares-more-about-profits-than-people/ Please subscribe and Share Visit our sister channel EVENT IS COMING SOON https://www.youtube.com/channel/UCJcmcStuyZVEkQheqINZjBA Fit Fornes https://www.youtube.com/channel/UC7b7i11pg-VcKWS7hZpjVBQ https://youtu.be/ULEhw0zW9ds
Просмотров: 60 To Your Health Body and Spirit
Breaking News  - Profit from the Made in Britain boom
 
08:23
Britain may not be the industrial giant it once was, but our factories are thriving.Manufacturing output has risen for the past eight months, marking the longest run of expansion for nearly 30 years and confounding predictions of decline.Overall, factory output rose by 2.3 per cent  in the last three months of 2017, according to the Office for National Statistics.So how can you take advantage of the revival to give your Isa a boost?Britain's pharmaceutical sector is booming and is home to some of the world's biggest drug companies.The sector employs more than 61,500 people and exports nearly £30 billion of medicines each year, according to the European Federation of Pharmaceutical Industries and Associations.In December, drug-makers were the second-fastest growing area of British manufacturing, according to the ONS.For savers wanting to profit, Darius McDermott, of fund supermarket Chelsea Financial Services, tips Threadneedle UK Equity Alpha Income.It invests nearly £13 in every £100 of your cash in drugs giants AstraZeneca and GlaxoSmithKline.Cambridge-based AstraZeneca, which rebuffed a £70 billion takeover bid from US rival Pfizer in 2014, was given a boost this week by the U.S. drug regulator's decision to grant approval to one of its key new cancer medicines.The Food and Drug Administration approved Imfinzi for treating stage three lung cancer patients who have had chemotherapy and radiotherapy.Analysts believe the move could be worth up to $2 billion (£1.4 billion) in annual sales to Astra, which employs 6,700 people at seven sites in the UK.This month, GlaxoSmithKline reported a 3 per cent rise in annual turnover to £30.2 billion, with profits rising 5 per cent to £8.5 billion.It is hopeful new treatments for lung conditions, HIV and shingles will help it continue to grow. It employs 16,000 people at 18 UK sites.Threadneedle UK Equity Alpha Income has turned £10,000 into £14,904 in five years.Britain's food, drink and tobacco manufacturers are also growing strongly, up 0.9 per cent in December, according to figures.Food and drink is the UK's biggest manufacturing sector, employing more than 400,000 people and generating more than £112 billion for the economy, according to trade body Food & Drink Federation.Ben Yearsley, of adviser Shore Financial Planning, believes Troy Trojan Income is one of the best ways to profit from the sector and resurgence of manufacturing as a whole.The second biggest holding in the fund, which has turned £10,000 into £14,727 in five years, is Unilever, which makes a range of foods such as Flora margarine, Hellman's mayonnaise as well as household brands such as Dove.It claims its products are in around 98 per cent of UK homes and used by two billion people globally each day.The London-based firm, has three UK research centres and multiple factories. Its share price has risen 41 per cent in five years, and it is the world's second largest advertising spender.Mr Yearsley says: 'Despite all of the doom and gloom ab AutoNews- Source: http://www.dailymail.co.uk/money/investing/article-5414683/Profit-Britain-boom.html?ITO=1490&ns_mchannel=rss&ns_campaign=1490
Просмотров: 3 US Sciencetech
PPCChamp Client Review - "We Made over 3.5 Crore in Sales" -  Sahil Sharma MD at JM Healthcare
 
01:56
Sahil Sharma is the Director of JM Healthcare Pvt. Ltd. - A Reputed Third Party Pharma Manufacturing Company based in Chandigarh. In this video one of our Clients Mr Sahil Sharma shared his words of appreciation with us after we successfully delivered digital marketing services. Looking for the Best Digital Marketing Agency in India for your business then look no further than PPCChamp as we can help you with all your Digital Marketing, Social Media Marketing, SEO related activities etc. Contact Details: PPCChamp – Digital Marketing Company Address: Building Number- 54-55, Sector 34 A Chandigarh India -160022 Phone Number: +91-9501488575, +91-9878873077 Email: Info@ppcchamp.com Website: http://www.ppcchamp.in/ Skype: PPC.Champ
Просмотров: 81 PPCChamp Digital Marketing Company
Excel  - Stock Group Wise Sales Analysis In Excel Conditional Formatting -  Excel Video
 
07:58
In this Video, Stock Group Wise Sales Analysis Given. Go Through this Video and Analyze Your Product group sales Report in Excel With Conditional formatting.To Download the Excel Sheet Click the Below Link visit our blog: http://goodwilllearningworld.blogspot.in/ send Mail to: goodwilllearningworld@gmail.com goodwilllearningworld@outlook.com Follow us on Twitter: https://twitter.com/gw_learning Visit And Subscribe Our YouTube Channels to View All Videos And Updates https://www.youtube.com/c/GoodwillLearningWorld Download: Product Group wise Sales Analysis in Excel : https://drive.google.com/file/d/1HvqnpQEphsf_0nhSy56aEOEzp7QFHwcJ/view?usp=sharing
Просмотров: 359 Goodwill Learning World
Empire Files;  Death & Biostitutes;  The US Opioid Crisis
 
21:57
https://www.telesurtv.net/english/news/Empire-Files-Abby-Martin-Talks-US-Opioid-Crisis-With-Mike-Papantonio-20171130-0017.html In 2016, 64,000 people died from drug overdoses in the United States, with roughly 80 percent of those deaths connected to opioids, according to a new report. The level of addiction has increased by almost 500 percent over the last six years. RELATED: Critics Say Trump's Opioid Epidemic Plan Is 'Counteractive' However, the question hanging on every concerned parent’s lips is where so many people could possible access that amount of drugs. Attorney Mike Papantonio believes the answer is as close as neighborhood clinics. In an exclusive interview with Abby Martin, the law professional — who made his name with triumphant lawsuits against big tobacco, chemical corporations and more — said he plans to take the United States' opioid crisis by the horns. Statistics show that 95 percent of suboxone sold in the world is sold in the United States and that one week of opioid use is enough to kick-start a severe addiction. With support from major distributors, pharmaceutical producers like Purdue Pharma were able to get their products into every hospital in the nation. Cleverly-crafted informative pamphlets describing addiction-free painkillers as well as pressure from federal health departments for critics was all it took to introduce dangerous substances such as Oxycodone into a patient’s daily prescription. Papantonio said that companies like Purdue are not the only corporations at fault. Major distributors like McKesson, Cardinal Health and AmerisourceBergen kept the lie alive when training new doctors. These distributors specifically targeted the nation’s poorer areas, former industrial towns with high unemployment, like Detroit, and poverty-stricken mining sectors in West Virginia. “They had done their homework and they figured out if somebody’s out of a job or somebody’s moved from the middle class to barely staying alive, that there’s despair that follows," he said, adding that investigations show that these sections are booming with distributors. The lawyer pointed to the growing number of sales, saying that in a town with a population of three million, distributors might sell as many as 700 million opioids. The addiction rate in these lower-class sectors has rocketed, transforming what began as a US$500 billion company into a US$500 billion industry almost overnight. “What they did, is they made this addiction issue part of their business plan,” Papantonio said. "They internalized what was happening out there on the street to become part of their business." He added that opioids then become a gateway drug for heroin. The pattern between former distribution hubs and spikes in heroin overdose admittances provide ample proof. “People ask me all the time, ‘Well, is this bigger than tobacco?’ This is much bigger than tobacco. This targeted our children,” Papantonio said. Although medical professionals are now taking action, the damage has already been done and only taking down these major corporations will make a difference for future generations, he added. RELATED: Cherokee Nation Sues Drug Firms over Opioid Crisis “My goal and what I’m doing nationally, I want to get all these cities and states, I want to get their money back for them, but I really want to make sure that some of them (corporate leaders) go to prison.” Papantonio explained that if they’re caught, the only regulation in place able to punish a corporation is the 1970s-era Substance Act, which only requires companies pay a fine for misdemeanors. Frequently, however, these same corporations will turn around and write off the fine as a business expense, leaving the federal government and taxpayers to “flip the bill.” The attorney said he’s hoping to take these companies to court with separate cases for each entity, adding that unlike other lawyers before him, he has no intention of settling. In the past, attorney generals have walked away from their cases after a US$50-$100 million settlement, a menial sum to a major corporation. “Yeah, they wear Armani suits and they have Rolex watches and they drive Bentley’s around. They come from great schools and live in Hamptons, and so we don’t look at them like criminals, so we don’t put them in prison.”
Просмотров: 3502 aplanetruth.info
✅ Pharmaceutical Companies Develops Medicines Animation Promotional Video: Logistic Supply Chain
 
00:54
Do you want to know more about us. Contact us at: ✔ www.missaudiovideo.com ✔ Skype: whiteboard.animation ✔ hello@missaudiovideo.com ✔ Call/Whatsapp: +919950099076 ★ Delivery in 24 Hours ★ Unlimited Revisions Guarantee ★ High-Quality, Top-Notch Script ★ Pool of Professional Voiceover Artist ★ Be It Any Language, We’ll Do It In All ★ 100% Satisfaction Guaranteed! ★ VERY Affordable! ★ Good At Meeting Deadlines ★ 100% Custom Art ★ Full HD, Outstanding Graphics Visit https://www.youtube.com/channel/UCs5LIHSO-2CJtogZcBudUxA for more information on the explainer video styles that we offer! A video explainer is one of the most cost-effective DIGITAL MARKETING tools available online. === Contact us today at hello@missaudiovideo.com to discuss about your project === We at missaudiovideo.com, aim to cater to the needs of our customers by providing them a variety of video options, such as explanation video, corporate video, company video, explanation animation, company video, corporate video, music video production, training videos, promotional video, online learning video and lots more! We have also ventured into providing services such as kick-starter video, start-up video, app promo video, animated info graphics and ‘save the date’ video. Don’t want your video in Hindi or English? No problem! We also make the video in German language. We also give our clients the option to make the video using whiteboard animation, stop motion and many other techniques to communicate their video in the perfect manner! Explainers Video make a huge impact on any product or service they advertise. We look forward to hear from you ! Explainer animation videos give you an unlimited space to turn your creative ideas into an engaging piece of motion art! We use various animation techniques to craft unique explainer videos that deliver your message to your target audience in minutes! Skriptumschrift unten (In German): Kopfschmerzen können selbst Tage mit frühem Feierabend und Sonnenschein vermiesen. Kopfschmerztabletten lösen das Problem. Dafür müssen sie nur zu Ihnen kommen. Die Pharmaindustrie entwickelt Medikamente, die genau zum Problem passen... und produziert die Tabletten nach hohen Standards. Sie werden dann sicher zu Ihnen transportiert. Mit LKWs,... Flugzeugen... Die Tabletten kommen in ein Flugzeug, das abhebt. Die Pilotin winkt aus dem Flugzeugfenster. durch den Zoll und mit Zügen Sie werden sicher aufbewahrt bis sie gebraucht werden Dann hilft modernste IT und die Tabletten kommen auf dem schnellsten Weg zu Ihnen In Ihrer Apotheke. Damit Sie Ihren Feierabend einfach geniessen können Script Transcript Below (In English): Headaches can even spoil days with early work and sunshine. Headache tablets solve the problem. They just have to come to you for that. The pharmaceutical industry develops medicines that exactly fit the problem ... and produces the tablets to high standards. They will then be safely transported to you. With trucks, ... Aircraft ... The tablets come in an airplane that takes off. The pilot waves from the airplane window. through customs and trains They are stored safely until they are needed Then state-of-the-art IT helps and the tablets will come to you the quickest way In your pharmacy. So that you can simply enjoy your evening Do you want to know more about us Contact at www.missaudiovideo.com Let's connect! ❤ Subscribe to our Youtube channel: https://www.youtube.com/channel/UCs5LIHSO-2CJtogZcBudUxA ❤ Follow us on Facebook: https://www.facebook.com/missaudiovideo/ ❤ Follow us on Linkedin: https://www.linkedin.com/in/chaheti-rawat-26148611b/ ❤ Follow us on Twitter: https://twitter.com/missaudiovideo ❤ Follow us on vimeo: https://vimeo.com/user49169357 Let’s begin the journey to your amazing explainer video!
DRF 19: Cardiovascular Outcomes for Diabetes Drugs: Lessons Learned and Path Forward
 
58:28
Panel Q&A moderated by Christopher Granger, MD FAHA, FACC with: • Eric Peterson, MD • Jennifer Green, MD • Neha Pagidipati, MD • Matthew Roe, MD, MHS
Просмотров: 176 Duke Clinical Research Institute
How Much Do Medical Aesthetics Make?
 
01:00
Medical esthetician salaries by education, experience, location and how much do medical aestheticians make? Outstanding collegesnational laser institute. What makes medical esthetics unique is that it performed on patients in a clinical their duties may include providing skin treatments, teaching make up techniques and giving chemical peels. What is the average annual salary for medical esthetician? How much does a esthetician make? The median as of march 01, 2018, with range usually between however this can vary widely depending on variety factors 13 mar 2018 2 careers in aesthetics; 3 how to become nurse esthetician; 4 do estheticians make per hour? Estheticians, also known aestheticians and skin care specialists, are personal appearance professionals who focus facial body care, makeup artistry, hair removal skincare specialists earned 2016, according u. I will be takig medical esthetics this june, and hope to done by december. Medical aesthetics products specialty and brand pharmaceutical. How much does a medical esthetician earn? Youtube. Very often, medical aestheticians work with individuals that have skin damaged by trauma, disease or a procedure gone wrong. The job of a medical esthetician is to become esthetician, you should first look at taking program an esthetics school. Dec 2015 medical aesthetics doesn't focus on conditions the field is entirely focused helping people look and feel better. According to the bureau of labor statistics, skincare specialists earn an average salary per year medical esthetician salaries. What are my job prospects? Does anyone know how much i could make as an esthetician working for a plastic surgeon? Was this comment of mar 2018, the average pay licensed medical aesthetician is $16. What is an esthetician? Us news money us & world report. Googleusercontent search. One should expect to devote at 15 feb 2015 can an aesthetic doctor carry out a breast enlargement operation? What about plastic surgeons, what do they do? What's the role of dermatologists in all this? As far as i remember, there're always couple standard questions that get asked when meeting new acquaintance party dec 2017 buzzydoc is there help medical practices win more patients and increase sales without creating work for staff aesthetics operates under direction supervision dr. Son the low end, skincare specialists earned a 25th percentile salary of meaning 75 percent more than this amount. Aesthetic nurse salary how much money can you earn as an medical aesthetician job shadow. Thanks to the many scientific advances in medicine over last century, people are living longer, healthier lives. How much does it cost to train as an aesthetic nurse? Box navigation 05 a registered nurse, you must undertake foundation course in botox and dermal fillers minimum training requirement before start practising nurse. Medical aesthetician jobs what is a medical esthetician's salary? Certified aesthetics certification and career learn. Usually, medical aest
Просмотров: 3 new sparky
Arteric Answers: How do you foster innovation in a pharmaceutical marketing organization?
 
12:49
Hans Kaspersetz answers: "How do you foster innovation in medical device and pharmaceutical marketing organizations?" Then provides three examples of how Arteric fosters innovation.
Просмотров: 30 Arteric
Market volatility headed higher?
 
05:57
Hodges Funds Portfolio Manager Craig Hodges on the outlook for stocks.
Просмотров: 343 Fox Business
Dr. Reynaldo Bautista Jr. of DLSU - 11th GBC 2018
 
00:23
Dr. Reynaldo Bautista Jr. talks about his experience during the 11th Global Business Conference. Dr. Reynaldo Bautista Jr. graduated from the University of the Philippines, Los Baños with a Bachelor of Science in Agricultural Chemistry degree in 2002 and became a Licensed Chemist in 2003. He got his Master's degree in Business Administration in Ateneo de Manila University, Makati. He proceeded to get his Doctoral degree of Business Administration in De La Salle University where he is currently the Assistant Dean of the External Relations and Internationalization Office and a full-time faculty teaching Marketing Research and Methods of Research. Currently, he is taking up Master of Statistics in the University of the Philippines, Diliman. He has a 1 and 1/2 years experience as a medical representative, 6 years experience of university teaching, 7 years of marketing experience, and an article contributor in Manila Times, Manila Standard, and BusinessWorld. The 11th Global Business Conference is organized by the Association of Training Institutions for Foreign Trade in Asia and the Pacific (ATIFTAP), the Association of Marketing Educators (AME), and St. Scholastica's College-Manila. Sponsored by: C&E Publishing GOSAI Oreo Metrobank BusinessWorld Special thanks to Mr. Bill Rañola, a member of our events management team, for this post-conference interview video of Dr. Bautista Jr. For more details, you can check us on: Facebook: www.facebook.com/atiftap Website: www.atiftap.org
Просмотров: 15 11th GBC 2018
EP021: Commercial Sales, Advertising, and Music Festivals w. Stephanie Rosa
 
47:20
Episode 21: Commercial Sales, Advertising, and Music Festivals w. Stephanie Rosa Featuring: Stephanie Rosa, Commercial Sales & Advertising Mentor Bio: Stephanie Rosa has been in medical device sales since graduating college from the University of Illinois. She quickly rose to be the #2 device representative in her company. Stephanie has worked in various sales roles within the medical world. After a year sabbatical to travel the world alone, Stephanie returned back into medical sales and began to pursue her passion within the festival and music industry. Stephanie now works full time in a corporate sales role, while also running a 40 person media team dedicated to music festivals. Industry Overview: What do Commercial Sales Professionals do? Wholesale and manufacturing sales representatives sell goods for wholesalers or manufacturers to businesses, government agencies, and other organizations. They contact customers, explain the features of the products they are selling, negotiate prices, and answer any questions that their customers may have about the products. What does their work environment look like? Wholesale and manufacturing sales representatives work under pressure because their income and job security depend on the amount of merchandise they sell. Some sales representatives travel frequently. How do you become a Sales Professional? Educational requirements vary for sales representatives and depend on the type of products sold. If the products are not scientific or technical, a high school diploma is generally sufficient for entry into the occupation. If the products are scientific or technical, sales representatives typically need at least a bachelor's degree. What additional skills that they typically don’t teach in school do you need? New employees may be trained by going along with experienced workers on their sales calls. As they gain familiarity with the firm’s products and clients, the new workers gain more responsibility until they eventually get their own territory. Strong social skills, understanding how to persuade, network, and get people to like you play a crucial role. What is the pay? The median annual wage for sales representatives, wholesale and manufacturing, except technical and scientific products was $57,140 in May 2016. The median annual wage for sales representatives, wholesale and manufacturing, technical and scientific products was $78,980 in May 2016. Future demand in marketplace? Overall employment of wholesale and manufacturing sales representatives is projected to grow 5 percent from 2016 to 2026, about as fast as the average for all occupations. Employment opportunities should be best in independent agencies, which operate on a fee basis and represent several manufacturers, instead of buying and holding the product they are selling. Overall… Job opportunities should be best for those with previous sales experience. Although the large size of the occupations creates many job openings, the relatively high pay will also likely attract a large number of applicants. US news rates a sales representative as # 4 in best marketing jobs which ranks them based on 5 categories ( salary, job market, future growth, stress, and work-life balance); with marketing manager, sales manager, insurance sales agent coming in 1st, 2nd and 3rd respectively. Todd's personal opinion… If you love to talk to people, are personable, like to travel, are up for a little bit of a cut throat industry where the potential to make good money right out of College this could be right up your alley. I know the medium numbers is $78K for technical, BUT, I have quite a few friends that make well over 7-figures selling products only a couple years out of college. In fact, a good friend of mine in the bay area sells carpet and makes 160K per year... and he isn’t even on the top! It requires charisma, high energy, and you need to be good and persuading people to take action. Show Notes: [1:55] - Intro. [2:35] - Meet This Week's Guest... Stephanie Rosa! [3:38] - Commercial Sales Industry Overview. [8:03] - Stephanie's Industry Insights. [9:48] - How It All Started for Stephanie. [13:53] - Everyone Is a Sales Person. [15:21] - Climbing the Medical Sales / Corporate Ladder. [18:55] - Festival Squad & Stephanie's Crazy Average Day! [24:55] - A Word From the Mastermind Community! [26:52] - Value Beyond Dollars and Cents. [27:38] - Would You Do It Again? [28:40] - Stephanie's #1 Piece of Actionable Advice for Teens! [32:30] - Episode 21 Recap / Key Points. [33:40] - Questions From the Teenage Mastermind Students! [45 :00] - Outro. Mentor's Key Points: EVERYONE is a Sales Person. Even if you don't find yourself working in a "Sales" position, you most definitely will find yourself selling SOMETHING at some point... most likely... YOURSELF! The key to sales success, however, isn't talking... it's LISTENING! Pay Attention to the...
Просмотров: 1 Student-Tutor
Tata Motors Bags E-Bus Order | Top Stocks In News | 22nd Mar | CNBC Awaaz
 
02:12
Tata Motors has secured electric bus supply contracts in six Indian cities to provide 190 e-buses. Sun Pharmaceutical Industries, India’s largest drug maker, Wednesday said it got US FDA approval for its much awaited psoriasis drug Ilumya. Ilumya, generically called as tildrakizumab-asmn, falls in the category of specialty drugs CNBC Awaaz is India’s number one business channel and an undisputed leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence. Subscribe to the CNBC Awaaz YouTube channel here: https://goo.gl/g3rzrW Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz Like us on our CNBC Awaaz Facebook page: https://hi-in.facebook.com/CNBCAwaazIndia
Просмотров: 924 CNBC Awaaz
Hedge Fund Manager Jeremy Grantham- Quant Trader with Event Driven Strategies
 
02:34
Jeremy Grantham is a British investor and co-founder and chief investment strategist of Grantham, Mayo, & van Otterloo (GMO), a Boston-based asset management firm. GMO is one of the largest managers of such funds in the world, having more than US$118 billion in assets under management as of March 2015. Grantham is regarded as a highly knowledgeable investor in various stock, bond, and commodity markets, and is particularly noted for his prediction of various bubbles. Event-driven strategies concern situations in which the underlying investment opportunity and risk are associated with an event. An event-driven investment strategy finds investment opportunities in corporate transactional events such as consolidations, acquisitions, recapitalizations, bankruptcies, and liquidations. Managers employing such a strategy capitalize on valuation inconsistencies in the market before or after such events, and take a position based on the predicted movement of the security or securities in question. Large institutional investors such as hedge funds are more likely to pursue event-driven investing strategies than traditional equity investors because they have the expertise and resources to analyze corporate transactional events for investment opportunities. Corporate transactional events generally fit into three categories: distressed securities, risk arbitrage, and special situations. Distressed securities include such events as restructurings, recapitalizations, and bankruptcies. A distressed securities investment strategy involves investing in the bonds or loans of companies facing bankruptcy or severe financial distress, when these bonds or loans are being traded at a discount to their value. Hedge fund managers pursuing the distressed debt investment strategy aim to capitalize on depressed bond prices. Hedge funds purchasing distressed debt may prevent those companies from going bankrupt, as such an acquisition deters foreclosure by banks. While event-driven investing in general tends to thrive during a bull market, distressed investing works best during a bear market. Risk arbitrage or merger arbitrage includes such events as mergers, acquisitions, liquidations, and hostile takeovers.[66] Risk arbitrage typically involves buying and selling the stocks of two or more merging companies to take advantage of market discrepancies between acquisition price and stock price. The risk element arises from the possibility that the merger or acquisition will not go ahead as planned; hedge fund managers will use research and analysis to determine if the event will take place. Special situations are events that impact the value of a company's stock, including the restructuring of a company or corporate transactions including spin-offs, share-buy-backs, security issuance/repurchase, asset sales, or other catalyst-oriented situations. To take advantage of special situations the hedge fund manager must identify an upcoming event that will increase or decrease the value of the company's equity and equity-related instruments. Other event-driven strategies include: credit arbitrage strategies, which focus on corporate fixed income securities; an activist strategy, where the fund takes large positions in companies and uses the ownership to participate in the management; a strategy based on predicting the final approval of new pharmaceutical drugs; and legal catalyst strategy, which specializes in companies involved in major lawsuits. FAIR USE NOTICE: This channel may make use of copyrighted material. This channel gains no profit from broadcasted content. In accordance with Title 17 U.S.C. Section 107, the material on this channel is offered publicly and without profit, to the public users of the internet for comment, non-profit, educational, and informational purpose. No copyright is claimed. This content is being posted here for financial educational purposes, so that investors will have a better understanding of financial markets.
Просмотров: 1104 scottab140
California's drug transparency law yields early surprises
 
03:29
California’s first-in-the-nation drug pricing transparency law is beginning to kick in — and to spur copycats, with Oregon’s governor last week signing a law that requires drug companies to disclose cost components they have long considered proprietary. Whether they’ll actually reduce prices is a crapshoot. California has already pried loose new numbers that may seem deja vu: Valeant, a magnet for criticism over past price boosts, is about to raise the price of a generic glaucoma medication by 63 percent, and Teva Pharmaceuticals, the world’s biggest generic drugmaker, plans a 49 percent price bump May 1 for an inhaled solution to prevent asthma attacks, according to documents obtained by POLITICO. The notifications are early results of the California law that in January began requiring drug companies to give major purchasers 60 days’ notice of significant increases. While it doesn’t directly affect prices, proponents hope that advance warnings — and mandating that manufacturers justify the increases — will generate enough public pressure to hold down prices. The wholesale price for the medications that trigger the notifications will be available to the public next year. “We’re going to be able to look at industry pricing activity in a way the public and the rest of us haven’t been able to track before,” said Jane Horvath, who heads the National Academy for State Health Policy’s Center for State Rx Drug Pricing. Other experts remain dubious. “We’ve seen massive, massive price increases, and shame has not trumped profit. After a while, people get numb to it,” said Adams Dudley, a pulmonologist and director of the University of California, San Francisco’s Center for Healthcare Value. Indeed, both Valeant and Teva have weathered these controversies before — just not in advance of an actual price hike. Valeant in 2015 raised the price of Syprine, which treats a rare disorder, to $21,000 — more than 30 times what it had been five years earlier. Teva recently introduced a “lower-cost” generic for $18,000 for a bottle of 100 pills, 28 times the 2010 brand price. Valeant then came back with an “authorized” generic for $19,000. With stories like these playing out across the country, California sees another area where it can play national leader. Gov. Jerry Brown explicitly described the transparency measure — supported by a broad coalition of insurers, employers and advocates arrayed against vehement drug industry opposition — as a model for other states when he signed it in October. Several states, including Massachusetts and Nebraska, have similar legislation pending. More than 150 bills have been introduced nationwide to address at least some aspect of prescription drug costs, according to the National Academy for State Health Policy. The industry sees California as a leader, too, and sued to stop the law. In a statement when the complaint was filed in December, the drug lobby PhRMA contended that the law illegally attempts to "dictate national health care policy" and thwart competition but declined further comment. The next set of legal filings is due Monday. Pharma trade groups also filed suit over laws in Maryland and Nevada that attempt to tackle drug prices in other ways. Oregon could be next. The sponsors of Oregon’s new transparency law say they closely watched California’s progress as they developed their own measure and felt emboldened when Sacramento passed it. But a provision in the Oregon bill that would have required advance notification of significant price increases, like California does, was negotiated out before passage. “The pharmaceutical industry doesn’t compromise on anything. They just say ‘no,’” said the bill’s primary author, state Rep. Rob Nosse. But Nosse, a Portland Democrat, is pleased: “Our version of transparency, I would argue, is a little more aggressive than what [California] did,” he said. Oregon will require drug companies to reveal research and development costs, profits, total sales, marketing outlays and other information relevant to price increases over 10 percent a year beginning in July 2019. California’s law has several key parts that will take effect this year and next. The law’s next phase begins Oct. 1, when health plans will have to report to the state the top 25 medications prescribed to their participants, which drugs cost payers the most and which experienced the largest aggregate year-over-year price increases. Starting on Jan. 1, 2019, the state is required to launch a public database of those price increases. Advance notification of wholesale acquisition costs — basically drugmakers’ list prices for direct purchasers — was the first part to take effect. Most of the increases reported to major purchasers were under 10 percent, although the law requires notice only of jumps exceeding 16 percent over two years. Health care inflation overall has been running under 2 percent annually in recent years. The two largest increases in the documents made a
Просмотров: 8 NEWS HEADLINES CN1
Turmeric and omega 3s can cure diabetes – but you’ll never hear that from your doctor
 
04:40
The Event Is Coming Soon-Turmeric and omega 3s can cure diabetes – but you’ll never hear that from your doctor Have you ever wondered why diseases like diabetes remain so difficult to treat despite all the incredible advances seen in modern medicine? It’s a common question, but you’ve already missed the point just by asking it. That’s because the solution to diabetes is not found in modern medicine at all. Instead, nature has the answer to this and many of the other problems plaguing human health, and modern medicine is so focused on profits that your doctor is far more likely to mention Metformin than turmeric when discussing your diabetes treatment options. With tens of billions of dollars in annual diabetes drug sales on the line, it’s not surprising that many patients are steered toward these profitable “treatments.” With the mainstream media getting a lot of funding from pharmaceutical companies, you won’t hear much about natural diabetes solutions there, either. This is why sites like Natural News are enjoying so much popularity right now. People don’t want the toxic and expensive solutions that are trying but failing to treat their illnesses, and why would they when there are alternatives that are not only effective and safe but also dirt cheap? https://www.dailymotion.com/theeventiscomingsoon Read More/Article Source Link/Credit(FAIR USE): https://www.naturalnews.com/2018-03-28-turmeric-and-omega-3s-can-cure-diabetes-youll-never-hear-from-your-doctor.html To Your Health Body and Spirit https://www.youtube.com/channel/UCDs86lPm4dF5kfMOA94TSKQ ----------------------------------------------------------- Please visit our Playlist for additional intel: The Event Intel https://www.youtube.com/playlist?list=PLZX49q1VM8O0p0XzU10aCLsSS92iTVQeg Disclosure https://www.youtube.com/playlist?list=PLZX49q1VM8O0C40VKZcQt-GRdpRaUy4lh Politics https://www.youtube.com/playlist?list=PLZX49q1VM8O0wTVaYupBh1Rq17yto_52t Energy Update https://www.youtube.com/playlist?list=PLZX49q1VM8O00lKekMXttP5HJvoGEQgPa&disable_polymer=true Newest Videos https://www.youtube.com/playlist?list=PLZX49q1VM8O0c5ifCAZSE3J0pRR9BcgUI The Event Is Coming Soon https://www.youtube.com/channel/UCNdcqCdkJ-EFv0IEU79MDUA SUPPORT US USING OUR LINKS! https://youtu.be/uqF_pNnnKj4 ----------------------------------------------------- http://twitter.com/eventcomingsoon
Просмотров: 727 The Event Is coming soon
Fresh Email Database 2018
 
01:14
So you're a businessman and you want to run a successful business but getting in touch with the right customers it's not as easy as you thought it was as the conversion rates of your sales team but it rock bottom because they arn't contacting the right people you have two options you can either spend ages and creating a list of valuable contacts who would be interested in your service or you can logon to www.freshemaildatabase.com and simply buy the email database of you the target customers from us it's a no-brainer whether you own a pharmaceutical company or a jewelry retail business we can get you the golden lists that can increase your conversion rates , our databases are always up to date with the latest email address his phone numbers contact info and many other forms of contact info there or even categorically organized for your convenience just log onto logon to www.freshemaildatabase.com instantly purchase and download a male databases that can optimize your marketing strategy
Просмотров: 14 Email Marketing
California's drug transparency law yields early surprises
 
08:23
California’s first-in-the-nation drug pricing transparency law is beginning to kick in — and to spur copycats, with Oregon’s governor last week signing a law that requires drug companies to disclose cost components they have long considered proprietary. Whether they’ll actually reduce prices is a crapshoot. California has already pried loose new numbers that may seem deja vu: Valeant, a magnet for criticism over past price boosts, is about to raise the price of a generic glaucoma medication by 63 percent, and Teva Pharmaceuticals, the world’s biggest generic drugmaker, plans a 49 percent price bump May 1 for an inhaled solution to prevent asthma attacks, according to documents obtained by POLITICO. The notifications are early results of the California law that in January began requiring drug companies to give major purchasers 60 days’ notice of significant increases. While it doesn’t directly affect prices, proponents hope that advance warnings — and mandating that manufacturers justify the increases — will generate enough public pressure to hold down prices. The wholesale price for the medications that trigger the notifications will be available to the public next year. “We’re going to be able to look at industry pricing activity in a way the public and the rest of us haven’t been able to track before,” said Jane Horvath, who heads the National Academy for State Health Policy’s Center for State Rx Drug Pricing. Other experts remain dubious. “We’ve seen massive, massive price increases, and shame has not trumped profit. After a while, people get numb to it,” said Adams Dudley, a pulmonologist and director of the University of California, San Francisco’s Center for Healthcare Value. Indeed, both Valeant and Teva have weathered these controversies before — just not in advance of an actual price hike. Valeant in 2015 raised the price of Syprine, which treats a rare disorder, to $21,000 — more than 30 times what it had been five years earlier. Teva recently introduced a “lower-cost” generic for $18,000 for a bottle of 100 pills, 28 times the 2010 brand price. Valeant then came back with an “authorized” generic for $19,000. With stories like these playing out across the country, California sees another area where it can play national leader. Gov. Jerry Brown explicitly described the transparency measure — supported by a broad coalition of insurers, employers and advocates arrayed against vehement drug industry opposition — as a model for other states when he signed it in October. Several states, including Massachusetts and Nebraska, have similar legislation pending. More than 150 bills have been introduced nationwide to address at least some aspect of prescription drug costs, according to the National Academy for State Health Policy. The industry sees California as a leader, too, and sued to stop the law. In a statement when the complaint was filed in December, the drug lobby PhRMA contended that the law illegally attempts to "dictate national health care policy" and thwart competition but declined further comment. The next set of legal filings is due Monday. Pharma trade groups also filed suit over laws in Maryland and Nevada that attempt to tackle drug prices in other ways. Oregon could be next. The sponsors of Oregon’s new transparency law say they closely watched California’s progress as they developed their own measure and felt emboldened when Sacramento passed it. But a provision in the Oregon bill that would have required advance notification of significant price increases, like California does, was negotiated out before passage. “The pharmaceutical industry doesn’t compromise on anything. They just say ‘no,’” said the bill’s primary author, state Rep. Rob Nosse. But Nosse, a Portland Democrat, is pleased: “Our version of transparency, I would argue, is a little more aggressive than what [California] did,” he said. Oregon will require drug companies to reveal research and development costs, profits, total sales, marketing outlays and other information relevant to price increases over 10 percent a year beginning in July 2019. California’s law has several key parts that will take effect this year and next. The law’s next phase begins Oct. 1, when health plans will have to report to the state the top 25 medications prescribed to their participants, which drugs cost payers the most and which experienced the largest aggregate year-over-year price increases. Starting on Jan. 1, 2019, the state is required
Просмотров: 1 NEWS HEADLINES CN1
Decision 2018: The race for governor. Democrats pre-assembly debate
 
55:43
Editor's Note: Due to a technical error at the beginning of the debate web stream, the first two minutes of the broadcast are omitted in this video. However, all of the questions and answers from the debate are included. The candidates did not make opening statements. READ | Introduction of the debate http://bit.ly/2qshngZ The participants in the Democrats debate on Wednesday were: - Former state senator Mike Johnston - Former state treasurer Cary Kennedy - Lieutenant Governor Donna Lynne Congressman Jared Polis was invited but declined to participate. The three candidates were largely in agreement on issues like gun control, TABOR, healthcare, immigration and the #MeToo movement – and each didn’t provide a definitive answer about whether they would give death row inmate Nathan Dunlap a reprieve.  This debate was held three days before the Colorado state assembly, which will determine who ultimately makes the primary ballot.  RELATED: Why 9NEWS is hosting its first Gubernatorial debates now: https://on9news.tv/2v6irfd Stay connected: 9News Website: http://www.9news.com/ Facebook: https://www.facebook.com/ilike9news Twitter: https://twitter.com/9NEWS Instagram: https://www.instagram.com/9newsdenver/ Google+: https://plus.google.com/+9news/posts Snapchat: Denver9NEWS Pinterest: https://www.pinterest.com/9news/
Просмотров: 1347 9NEWS
Overdose Deaths Are the Product of Drug Prohibition
 
08:21
During Prohibition, drinkers never knew what they would get when they set out to slake their thirst. Bootleggers often sold products adulterated with industrial alcohol and other toxins. Some 10,000 people were fatally poisoned before America gave up this grand experiment in suppressing vice. So it was a tragedy but not a total surprise when three deaths were reported in Illinois from synthetic marijuana laced with an ingredient (possibly rat poison) that caused severe bleeding. Nationally, in 2015, says the Drug Policy Alliance, "poison control centers received just under 10,000 calls reporting adverse reactions to synthetic cannabinoids, and emergency rooms received tens of thousands of patients." People consume synthetic cannabis for the same reason people once consumed bathtub gin: Their drug of choice is illegal. Criminal organizations that cater to forbidden demands don't always make a fetish of quality control. After Prohibition was repealed, though, tipplers could buy from legal, regulated suppliers. They no longer had to worry about ingesting sudden death. In nine states and the District of Columbia, pot users now enjoy the same protection. Recreational marijuana is allowed and subject to government regulation and the discipline of the market—ensuring purity through accountability. But in most places, Americans who want to get high have to take their chances with unsanctioned dealers who may be sorely lacking in moral scruples. The bigger toll from modern drug prohibition, however, comes among opioid users. By making criminals of many people who are dependent on prescription painkillers such as oxycodone and hydrocodone, the law exiles them to the black market. There, consumers may find legitimate FDA-approved medicines, but they may also buy counterfeit versions or heroin—which often carry far greater hazards. The most urgent danger comes from fentanyl, an opioid at least 30 times more powerful than heroin that illicit producers often mix with other opioids. It plays a rapidly growing role in the epidemic of drug overdose deaths. The number of deaths caused by fentanyl and other synthetic opioids, says the National Center for Health Statistics, increased by 88 percent per year from 2013 through 2016. In 2016, these drugs killed more than 19,000 people. Why would traffickers cut a dangerous drug (heroin, oxycodone) with an even more dangerous one? Fentanyl's low cost and high potency allow sellers to make more money. The iron law of prohibition stipulates that banning a substance encourages more powerful alternatives because they are more compact and thus easier to hide (boxes of pills versus bales of marijuana). The side effect is to greatly compound the dangers of drug use. As if its role in opioids weren't bad enough, fentanyl has shown up in cocaine. Law enforcement agencies in Connecticut and Massachusetts report a surge in this particular mixture, which is especially dangerous because cocaine users usually lack a tolerance for
Просмотров: 6 Ecuuaio fuigqcy
Introduction to Pharmacology, Drug Development and Clinical Pharmacology - Module 1, Session 2
 
36:36
Introduction to Pharmacology, Drug Development and Clinical Pharmacology - Module 1, Session 2 with Dr. William D. Figg This is Module 1, Session 2, of the NIH Clinical Center's "2017-2018 Principles of Clinical Pharmacology" course. The course is a lecture series covering the fundamentals of clinical pharmacology as a translational scientific discipline focused on rational drug development and utilization in therapeutics. If you have any questions or need additional information regarding the Principles of Clinical Pharmacology course, please email the course coordinator at: cc-od_clinp@mail.nih.gov.
Просмотров: 1527 NIH Clinical Center
Abandoned Pilgrim State Psychiatric Center
 
01:17:43
Apologize had to remove the song from the beginning so no sound for 2 min. We explore the abandoned pilgrim psychiatric center. This center in 1954 was home to over 13,000 patients. Join us as we explore the remnants of this old facility. After World War II, Pilgrim State Hospital experienced an increase in patient population that made it the world's largest hospital, with 13,875 patients and over 4,000 employees. In the 1950s more aggressive treatments, such as lobotomy and electro-convulsive therapy (ECT) were implemented. The best known controversy about this surrounded the case of Beulah Jones, a patient there between 1952 and 1972 who received both such treatments and was left seriously impaired. However, Pilgrim State Hospital and the other state hospitals began to decline shortly afterwards with the advent of pharmaceutical alternatives to institutionalization. Dr. Henry Brill served as the director of Pilgrim from 1958 to 1974 and presided over both the introduction of the new anti-psychotic medications and the large numbers of discharges related to good response to these medications. Be sure to check out all our channels and videos below: Urban Ghost Urban Exploration (UGUE): https://www.youtube.com/channel/UCSzuL8cKMva9fQxjENTb9tw The G-Team Paranormal: https://www.youtube.com/channel/UCRERFUVI8WDxoN3JVzmp6UQ Be sure to also check out our social media social media: Instagram: holywalk_s t Twitter kyle and Ethan: @IN2-Wonderland_E Twitter Todd holywalker's: @holywalkers_s Twitter Ethan holywalker's: @holywalkers_E Facebook: Holywalker's Music:BLACKOUT / NO CEILINGS (Prod. Wocki Beats) by EULOGY THE SEWER GOD https://soundcloud.com/eulogy2013/blackout-no-ceilings-prod-wocki-beats-1 on #SoundCloud
Просмотров: 1027 HOLYWALKER' S
Overdose Deaths Are the Product of Drug Prohibition
 
08:21
During Prohibition, drinkers never knew what they would get when they set out to slake their thirst. Bootleggers often sold products adulterated with industrial alcohol and other toxins. Some 10,000 people were fatally poisoned before America gave up this grand experiment in suppressing vice. So it was a tragedy but not a total surprise when three deaths were reported in Illinois from synthetic marijuana laced with an ingredient (possibly rat poison) that caused severe bleeding. Nationally, in 2015, says the Drug Policy Alliance, "poison control centers received just under 10,000 calls reporting adverse reactions to synthetic cannabinoids, and emergency rooms received tens of thousands of patients." People consume synthetic cannabis for the same reason people once consumed bathtub gin: Their drug of choice is illegal. Criminal organizations that cater to forbidden demands don't always make a fetish of quality control. After Prohibition was repealed, though, tipplers could buy from legal, regulated suppliers. They no longer had to worry about ingesting sudden death. In nine states and the District of Columbia, pot users now enjoy the same protection. Recreational marijuana is allowed and subject to government regulation and the discipline of the market—ensuring purity through accountability. But in most places, Americans who want to get high have to take their chances with unsanctioned dealers who may be sorely lacking in moral scruples. The bigger toll from modern drug prohibition, however, comes among opioid users. By making criminals of many people who are dependent on prescription painkillers such as oxycodone and hydrocodone, the law exiles them to the black market. There, consumers may find legitimate FDA-approved medicines, but they may also buy counterfeit versions or heroin—which often carry far greater hazards. The most urgent danger comes from fentanyl, an opioid at least 30 times more powerful than heroin that illicit producers often mix with other opioids. It plays a rapidly growing role in the epidemic of drug overdose deaths. The number of deaths caused by fentanyl and other synthetic opioids, says the National Center for Health Statistics, increased by 88 percent per year from 2013 through 2016. In 2016, these drugs killed more than 19,000 people. Why would traffickers cut a dangerous drug (heroin, oxycodone) with an even more dangerous one? Fentanyl's low cost and high potency allow sellers to make more money. The iron law of prohibition stipulates that banning a substance encourages more powerful alternatives because they are more compact and thus easier to hide (boxes of pills versus bales of marijuana). The side effect is to greatly compound the dangers of drug use. As if its role in opioids weren't bad enough, fentanyl has shown up in cocaine. Law enforcement agencies in Connecticut and Massachusetts report a surge in this particular mixture, which is especially dangerous because cocaine users usually lack a tolerance for
Просмотров: 1 Ecuuaio fuigqcy
Company blamed for fueling fentanyl addiction crisis will soon sell synthetic cannabis
 
04:51
The drug manufacturer accused of fueling the opioid epidemic will soon be given the green light to market synthetic marijuana for medical use. The US Drug Enforcement Agency is close to approving a synthetic formula for THC, the main psychoactive component in marijuana, made by Insys Therapeutics. The company has said launching the new drug Syndros will be a 'pivotal milestone' to turn around Insys's reputation following several lawsuits alleging its top execs have been pushing prescriptions for fentanyl, an opioid that is 50 times stronger than heroin. The new drug could potentially replace highly addictive and dangerous drugs like fentanyl that are fueling the opioid epidemic that kills thousands of Americans each year. Medical-grade synthetic marijuana is not to be confused with street versions known as 'K2' or 'spice' that are an unpredictable mix of chemicals recently found to cause severe bleeding from the eyes and ears in Illinois. Medical synthetics are scientifically and specifically calibrated to mimic cannabinoids, the active compounds in marijuana that create the 'high'. They are similar to chemicals the body makes that are involved in appetite, memory, movement, and pain. The two main cannabinoids are THC and CBD. Syndros is a synthetic formula for THC. The main component of the drug, dronabinol, was first government-approved in pill-capsule form in 1985. It is sold under the name Marinol. Once it receives final DEA approval, Insys will be able to start selling oral spray intended to treat nausea, vomiting and weight loss in AIDS and cancer patients by mimicking THC. In November the DEA announced that Syndros will be classified as a Schedule II controlled substance, meaning it can be legally prescribed by doctors. Schedule II drugs including cocaine, fentanyl and morphine are considered to have a 'high potential for abuse'. Natural marijuana is currently listed in the more restrictive Schedule I category, which is reserved for drugs that have 'no currently accepted medical use'. The Schedule II classification indicates that the DEA considers the synthetic marijuana to be safer and more valuable that regular marijuana. Last fall Insys founder John Kapoor and several other top executives at the company were accused of offering bribes to doctors to write large numbers of prescriptions for the fentanyl-based spray called Subsys. Subsys was only approved by the FDA for used by cancer patients with severe nerve pain, but an investigation found that most of the people who received prescriptions did not have cancer. Although originally intended as a painkiller with medicinal uses, the substance has increasingly been used an illicit recreational drug and is often made illegally. More than 20,000 deaths occurred in the United States in 2016 from fentanyl overdoses alone. History of Insys in the cannabis community  In 2016 Insys helped block the legalization of recreational marijuana in Arizona by donating $500,000 to the group leading the opposition. At the time the company issued a statement that the ballot measure proposing legalization 'fails to protect the safety of Arizona's citizens, and particularly its children.' However, top members of the cannabis community noted the company's financial interest in minimizing competition for synthetic marijuana products, according to the Washington Post. A pro-legalization campaign member J.P. Holyoak said: 'It appears they are trying to kill a non-pharmaceutical market for marijuana in order to line their own pockets.' Tom Angell of pro-cannabis group Marijuana Majority added that accepting the donation from a company that has been [accused] of putting public health at risk goes against the anti-legalization group's message. 'Accepting this money undermines everything that marijuana prohibitionists say about their desire to protect public health,' Angell told the Post.  'It's difficult to understand how people who profit from selling a drug like fentanyl can keep a straight face while arguing that marijuana is just too dangerous to legalize.'
Просмотров: 13 NEWS HEADLINES CN6
Baum Century Series Print/Gather/Fold/Barcode Verification/Document Inserting System
 
03:06
The New Baumfolder Print, Gather, Fold, Inserting System. As the Konica Minolta 1250P prints the invoice, packing list, marketing material, document the Baumfolder system has a divert system installed that allows testing or jam prevention. This prevents most kinds of jams in the system; the flap will automatically come up and divert the sheets into an automatic tray that you can remove by hand. Normally the sheets will then go into an ionizer system that Baumfolder has installed. What does an ionizer do? It removes all that static electricity the copier has put into the sheets by heating the paper. Because, static if not removed can lead to jamming, double sheets curls when you are trying to insert into a box, static is your worse enemy. As the sheets come into the gathering system the round belts, gather the sheets on top of each other until the specified numbers of sheets are gathered. The gate will come down and release those sheets into the fold system. The Baumfolder folding system has been around for 100 years, doing various folds for all types of Graphic Industries. Then we go into the Baumfolder staging units. It is a belt over belt system. What this unique system does, as the sets of folded invoices, packing list, personalized documents are folded they go into a staging system that organizes the documents until the correct box has arrived down the conveyor system. Barcode verification was completed on the document and box verifying that both are the same. Then the document is inserted precisely into the box. As that box is inserted the next box comes down the conveyor line, and our system will automatically index those invoices in our staging system so we can insert as soon as the box is ready. Each unit comes with a personalized console system. This console will show verification codes, speed and error codes on the system. The touch screen can be mounted so the operator can easily read and clear jams or errors and keep production running. For more information please contact us at sales@baumfolder.com or call 800-543-6107
Просмотров: 175 Baumfolder Corporation
Industrial output increased 4.5% y/y in Jan.
 
01:34
1월 산업생산 전년동월대비 4.5% 늘어 South Korea's industrial output recovered in the month of January. This comes on the back of improved production in the auto and semiconductor sectors..., the traditional key drivers of the nation's growth. Kim Ji-yeon give us a rundown of the encouraging digits. Industrial output of overall industries in Korea increased four-and-a-half percent in January compared to the same period last year. Statistics Korea says output jumped one-point-two-percent from the previous month,... the steepest rate of increase in ten months. It attributes the spike to increased production in the auto sector, which grew more than twelve percent on-month... thanks to releases of new models and a base effect stemming from sluggish auto exports to the U.S. and the Middle East. A rebound in the auto and semiconductor sectors helped boost output in the mining and manufacturing sectors... which grew one-percent from the previous month in January... the first on-month increase in three months. Retail sales also spiked one-point-seven percent from the previous month on increased output of automobiles and durable goods. A rebound in the auto sector also helped to boost facility investment which rose by more than six-percent from the previous month... the fastest rate of increase in ten months. Production in the services sector also jumped zero-point-eight-percent compared to the previous month,... mainly due to increased output in science and technology. However, output in the food and lodging sectors dropped one-point-three percent from the previous month... declining for the fourth straight month in January. Kim Ji-yeon, Arirang News. Arirang News Facebook: http://www.facebook.com/arirangtvnews ------------------------------------------------------------ [Subscribe Arirang Official YouTube] ARIRANG TV: http://www.youtube.com/arirang ARIRANG RADIO: http://www.youtube.com/Music180Arirang ARIRANG NEWS: http://www.youtube.com/arirangnews ARIRANG K-POP: http://www.youtube.com/arirangworld ARIRANG ISSUE: http://www.youtube.com/arirangtoday ARIRANG CULTURE: http://www.youtube.com/arirangkorean ------------------------------------------------------------ [Visit Arirang TV Official Pages] Facebook: http://www.facebook.com/arirangtv Twitter: http://twitter.com/arirangworld Instagram: http://instagram.com/arirangworld Homepage: http://www.arirang.com ------------------------------------------------------------ [Arirang K-Pop] YouTube: http://www.youtube.com/arirangworld Facebook: http://www.facebook.com/arirangkpop Google+: http://plus.google.com/+arirangworld
Просмотров: 55 ARIRANG NEWS
Overdose Deaths Are the Product of Drug Prohibition
 
08:21
During Prohibition, drinkers never knew what they would get when they set out to slake their thirst. Bootleggers often sold products adulterated with industrial alcohol and other toxins. Some 10,000 people were fatally poisoned before America gave up this grand experiment in suppressing vice. So it was a tragedy but not a total surprise when three deaths were reported in Illinois from synthetic marijuana laced with an ingredient (possibly rat poison) that caused severe bleeding. Nationally, in 2015, says the Drug Policy Alliance, "poison control centers received just under 10,000 calls reporting adverse reactions to synthetic cannabinoids, and emergency rooms received tens of thousands of patients." People consume synthetic cannabis for the same reason people once consumed bathtub gin: Their drug of choice is illegal. Criminal organizations that cater to forbidden demands don't always make a fetish of quality control. After Prohibition was repealed, though, tipplers could buy from legal, regulated suppliers. They no longer had to worry about ingesting sudden death. In nine states and the District of Columbia, pot users now enjoy the same protection. Recreational marijuana is allowed and subject to government regulation and the discipline of the market—ensuring purity through accountability. But in most places, Americans who want to get high have to take their chances with unsanctioned dealers who may be sorely lacking in moral scruples. The bigger toll from modern drug prohibition, however, comes among opioid users. By making criminals of many people who are dependent on prescription painkillers such as oxycodone and hydrocodone, the law exiles them to the black market. There, consumers may find legitimate FDA-approved medicines, but they may also buy counterfeit versions or heroin—which often carry far greater hazards. The most urgent danger comes from fentanyl, an opioid at least 30 times more powerful than heroin that illicit producers often mix with other opioids. It plays a rapidly growing role in the epidemic of drug overdose deaths. The number of deaths caused by fentanyl and other synthetic opioids, says the National Center for Health Statistics, increased by 88 percent per year from 2013 through 2016. In 2016, these drugs killed more than 19,000 people. Why would traffickers cut a dangerous drug (heroin, oxycodone) with an even more dangerous one? Fentanyl's low cost and high potency allow sellers to make more money. The iron law of prohibition stipulates that banning a substance encourages more powerful alternatives because they are more compact and thus easier to hide (boxes of pills versus bales of marijuana). The side effect is to greatly compound the dangers of drug use. As if its role in opioids weren't bad enough, fentanyl has shown up in cocaine. Law enforcement agencies in Connecticut and Massachusetts report a surge in this particular mixture, which is especially dangerous because cocaine users usually lack a tolerance for
Просмотров: 5 Dyfu osar
Overdose Deaths Are the Product of Drug Prohibition
 
08:21
During Prohibition, drinkers never knew what they would get when they set out to slake their thirst. Bootleggers often sold products adulterated with industrial alcohol and other toxins. Some 10,000 people were fatally poisoned before America gave up this grand experiment in suppressing vice. So it was a tragedy but not a total surprise when three deaths were reported in Illinois from synthetic marijuana laced with an ingredient (possibly rat poison) that caused severe bleeding. Nationally, in 2015, says the Drug Policy Alliance, "poison control centers received just under 10,000 calls reporting adverse reactions to synthetic cannabinoids, and emergency rooms received tens of thousands of patients." People consume synthetic cannabis for the same reason people once consumed bathtub gin: Their drug of choice is illegal. Criminal organizations that cater to forbidden demands don't always make a fetish of quality control. After Prohibition was repealed, though, tipplers could buy from legal, regulated suppliers. They no longer had to worry about ingesting sudden death. In nine states and the District of Columbia, pot users now enjoy the same protection. Recreational marijuana is allowed and subject to government regulation and the discipline of the market—ensuring purity through accountability. But in most places, Americans who want to get high have to take their chances with unsanctioned dealers who may be sorely lacking in moral scruples. The bigger toll from modern drug prohibition, however, comes among opioid users. By making criminals of many people who are dependent on prescription painkillers such as oxycodone and hydrocodone, the law exiles them to the black market. There, consumers may find legitimate FDA-approved medicines, but they may also buy counterfeit versions or heroin—which often carry far greater hazards. The most urgent danger comes from fentanyl, an opioid at least 30 times more powerful than heroin that illicit producers often mix with other opioids. It plays a rapidly growing role in the epidemic of drug overdose deaths. The number of deaths caused by fentanyl and other synthetic opioids, says the National Center for Health Statistics, increased by 88 percent per year from 2013 through 2016. In 2016, these drugs killed more than 19,000 people. Why would traffickers cut a dangerous drug (heroin, oxycodone) with an even more dangerous one? Fentanyl's low cost and high potency allow sellers to make more money. The iron law of prohibition stipulates that banning a substance encourages more powerful alternatives because they are more compact and thus easier to hide (boxes of pills versus bales of marijuana). The side effect is to greatly compound the dangers of drug use. As if its role in opioids weren't bad enough, fentanyl has shown up in cocaine. Law enforcement agencies in Connecticut and Massachusetts report a surge in this particular mixture, which is especially dangerous because cocaine users usually lack a tolerance for
Просмотров: 1 Dyfu osar
FreshEmailDatabase 2018
 
01:14
So you're a businessman and you want to run a successful business but getting in touch with the right customers it's not as easy as you thought it was as the conversion rates of your sales team but it rock bottom because they arn't contacting the right people you have two options you can either spend ages and creating a list of valuable contacts who would be interested in your service or you can logon to www.freshemaildatabase.com and simply buy the email database of you the target customers from us it's a no-brainer whether you own a pharmaceutical company or a jewelry retail business we can get you the golden lists that can increase your conversion rates , our databases are always up to date with the latest email address his phone numbers contact info and many other forms of contact info there or even categorically organized for your convenience just log onto logon to www.freshemaildatabase.com instantly purchase and download a male databases that can optimize your marketing strategy
Просмотров: 2 latest Indian viral sensation
Digital Pharma Europe exl AS
 
01:59
Digital Pharma Europe (exl) AS At Radisson Blu Edwardian, Heathrow For more information: https://www.eventbrite.com/e/digital-pharma-europe-exl-as-tickets-39219077316?aff=RMV DESCRIPTION ============ In an effort to provide our most diverse pharmaceutical and medical device executive mix to date, this year’s venue provides a centralized platform that is close to numerous UK pharma headquarters as well as Heathrow Airport. This will also allow for easy access to UK pharmaceuticals and medical device organizations and facilitate expedited travel time for European and US counterparts. By bringing together over 200 life-science industry marketers, you will be able to employ a roadmap for a fully digitalized enterprise — no what your core business offering is There are some exciting potential solutions on the horizon, but still many questions being asked: How will digital disruption transform the pharma business model? How can pharma leverage digital and navigate digital trends and technologies to maximise positive outcomes for patients? How can pharma generate value from digital medicine solutions? As pharma companies shift from implementing traditional products to connected solutions, companies are challenged to define and realise value from this new business model (e.g., revenue stream) that intelligent digital medicine solutions require. How can pharma engage with disruptive technologies? How can we demonstrate the value of digital for pharma products? Pharma companies are increasingly exploring the role that digital can play in demonstrating value through data, analytics, and real-world evidence. How will pharma adapt to successfully engage HCPs? As HCPs evolve in their engagement with patients and how they manage their practice, pharma companies will have to transform their HCP-engagement approach. We will explore these questions and more. Join the conversation and contribute to the advancement of digital health to improve patient outcomes and customer centricity! Reserve your seat for the 10th anniversary of the Digital Pharma Europe conference. We look forward to celebrating this milestone with you in London this May! For more information: https://www.eventbrite.com/e/digital-pharma-europe-exl-as-tickets-39219077316?aff=RMV “What Exactly Will I Learn?” ============================ Drive Optimized Marketing And Digital Operations, Launch Readiness And Marketing Capability By: Establishing product launch excellence and launch models for multiple therapeutic categories Measuring success in digital ROI and evaluating digital analytics Global digital transformation HCP user experience — user research — visualization and journey tools Enhancing commercial planning quality by increasing alignment among Marketing, Medical, Finance & Sales functions Improve the overall quality of strategic brand plans across BUs by developing a more patient-centric approach and delivering innovation in patient centricity Grow e-SOV for your brands by: ============================== Leveraging HCP portals across the globe — how to lead from strategy into deployment across high numbers of markets Digital engagement and programming for HCPs, 360 views, etc. Developing market-leading content strategy and targeting around e-mail magazines and Veeva approved e-mails Execute successful webcasts Improve handling of marketing material and increased i-detailing usage to increase rep call quality and sales The evolving tools and tactics of digital to improve patient quality of life and outcomes, e.g. AI and remote diagnostics Omnichannel optimization — identifying the optimal channel mix, timing of digital and sales visit that lead to drug adoption Optimized content production through the set up of a new asset management process Please contact the event manager Marilyn below for the following: - Discounts for registering 5 or more participants. - If your company requires a price quotation. Event Manager Contact: marilyn.b.turner(at)nyeventslist.com You can also contact us if you require a visa invitation letter, after ticket purchase. We can also provide a certificate of completion for this event if required. ---------------------------------- For more information: https://www.eventbrite.com/e/digital-pharma-europe-exl-as-tickets-39219077316?aff=RMV Eventbrite: https://www.eventbrite.com/o/event-promotions-by-new-york-events-list-11118815675 Twitter: https://twitter.com/nyeventslist Facebook: https://www.facebook.com/NewYorkEventsList New York Events List: http://nyeventslist.com/
Просмотров: 5 New York Events List
Retail Industry: Digital Transformation, Customer Experience, and Innovation (CXOTalk #282)
 
48:56
How is the retail industry changing and innovating? How about the role of customer experience and change agents? For more information and to read the complete transcript, see https://www.cxotalk.com/episode/digital-transformation-retail-innovation-changes Dana Randall, head of innovation at Tapestry, speaks with CXOTalk and guest co-host Brian Solis about digital transformation in retail businesses. The company, which includes the brands Coach and Kate Spade, is rethinking traditional sales and adapting to shifts in social, cultural, technology and consumer expectations. Dana Randall is the Head of Innovation at Tapestry, helping to drive innovation in retail through strategic partnerships with technology companies and startups. She has been listed by Digiday in The Glossy 50 recognizing the leaders creating change in fashion, luxury, beauty, and tech, as well as named as one of Brand Innovators 40 Under 40 & Women to Watch.
Просмотров: 5900 CXOTALK
Applying Lessons Learned from the Master Settlement Agreement with Big Tobacco to Other Industries
 
01:12:43
The landmark 1998 Master Settlement Agreement (MSA) between 46 state’s attorneys general and the US tobacco industry set in motion an unprecedented decline in tobacco consumption, saving millions of lives and potentially billions of dollars. Putting public health ahead of corporate profit was a hard-fought battle, and lessons from the tobacco wars could have significant value in approaching similar manufacturers—including the pharmaceutical and sugar-sweetened beverage industries—in an effort to dramatically decrease the opioid and obesity crises. Speaker: Cheryl Healton, Dean, College of Global Public Health, New York University
Просмотров: 120 BU School of Public Health
Watch Now | Mazda Skyactiv-X Review | The revolution begins with a squeeze-bang
 
03:42
Mazda Skyactiv-X Review | The revolution begins with a squeeze-bang DESCRIPTION : The matte black Skyactiv-X prototype looks like a rough Mazda3, perhaps reconstructed after a bad wreck by an over-enthusiastic owner of a spot welder and lots of gaffers' tape. Ribbed ducts poke out of the dash sending two breaths of conditioned air to no one in particular. Even its revolutionary engine, the thing we're here to experience, is entombed in a massive, nondescript cover to mask its unseemly noises. It's a wild, strange way to meet a very unconventional vehicle that promises diesel-like fuel economy, a wide torque band, and an exotic method for burning less gas than ever before. It takes a few hours for Mazda's engineers to explain the fundamental principles of operation. For more detail, read our Skyactiv-X Spark Controlled Compression Ignition explainer, but here's a very brief overview. Skyactiv-X is complex, and Mazda Vice President of R&D and Design Masashi Otsuka admits it will be an expensive engine to build. "But," he said to us before we drove the cars, with a big lopsided smile, "it's less expensive than a hybrid." That speaks to Mazda's philosophy in building the Skyactiv engine range in general. Mazda has avoided electrification almost entirely; what electrification it employs is either very minimal (i-eLoop regenerative braking and capacitor system) or niche (Demio EV, with its rotary range extender option). Rather than build a bunch of hybrids and EVs that are dependent on incentives to sell (and still don't sell that well — Mazda does have a point here), the company decided long ago to just improve the internal combustion engine as much as possible. That means it has the lowest average EPA fuel economy of any manufacturer — although its overall volume is small, its sales have suffered recently, and it doesn't sell any large and inefficient SUVs or trucks. Mazda's strategy is technically sound, but perhaps not as effective in the real world as it might hope. Then again, as the company is eager to point out, neither is the real-world economy of the downsized, turbocharged engine trend. They're great at EPA testing but miserably thirsty in the real world. Skyactiv-X isn't the final result of this process; there will be more electrification as that becomes necessary and/or demanded by the marketplace. There's a next-generation pure diesel engine coming, after the long-delayed Skyactiv-D engine, using lessons and perhaps technologies developed for Skyactiv-X. But for now, Skyactiv-X is the absolute bleeding edge. Which is not how it feels on the road in the least. It's not supposed to feel bleeding edge, to be fair. There are rough edges, too. But mostly, it feels like a direct-injected, high-compression gasoline-powered car. It does not feel supercharged in the traditional sense, either. Off the line, it's definitely perkier than the anemic 2.0-liter Skyactiv-G engine, and on par with the 2.5-liter nonturbo Skyactiv-G on paper, although the -X's torque curve is fatter. The torque wave continues as revs increase, authoritative but not necessarily sporty. If you want to talk numbers, they're understandably fuzzy. The Skyactiv-X tune isn't final yet, so horsepower and torque figures are a moving target. In Frankfurt, Mazda said the prototype engine was making about 187 horsepower and 143 pound-feet of torque. At Mazda HQ in California, the numbers bandied about are closer to 190 horsepower and 180 lb-ft of torque. That compares favorably with the 2.5-liter Skyactiv-G, which makes 184 hp and 185 lb-ft of torque in the Mazda6 and 187 hp/186 lb-ft in the CX-5. The numbers also differ from the Skyactiv-D diesel, which makes around 173 hp and 310 lb-ft in other markets where its currently sold. https://www.youtube.com/channel/UCcSge9UOAFWMIIYouchvLOg?sub_confirmation=1 1. https://www.youtube.com/watch?v=zje_64ouCwA 2. https://www.youtube.com/watch?v=Jsu0BvUhqCk 3. https://www.youtube.com/watch?v=B4SaB42UJHk
Просмотров: 0 automotive news
How Much Do Entry Level Software Engineers Make?
 
01:00
Does a software engineer at google make $3 million year? Sokanu in north carolina. The vast majority of employed entry level software 9 jan 2018 interviewing engineers could be even more difficult because theoretically they lack a basic understanding writing. If after the probation period, you are performing at level beyond junior software engineer, a salary adjustment would be considered in $85k arena, 14 jan 2014 but how much non compensation do google engineers really make? Assuming these numbers accurate and representative of general (a leap faith, for sure, it's best data i could find), your average lower engineer there makes $145k per year, make good engineer? Take our career test to find out does north carolina? According glassdoor, which gathered information from over 15,000 engineers, national entry is feb 2018 bear mind though, that actual annual income ukrainian can as well significantly higher than this switzerland, developers generally close $84k while senior approximately $115k (according year? The pay job us year. Glassdoor glassdoor entry level software engineer salary srch_ ko0,29. Ziprecruiter scanned its database of millions jobs in order to estimate the most accurate salary range for entry level software engineer united states 42418 salaries san jose, ca provided anonymously by employees. How to interview entry level software engineers clover health. What salary does a entry level software engineer earn in your area? How much make? The national average for is united states. How much does an entry level software engineer make? Quora. Last year, clover engineering created its entry level engineers. Depends on where you live and get hired 1 entry level information a security analyst's salary; 2 how much money do pharmaceutical sales reps make? 3 cs vs4 the average salaries of front end web developers. The average pay for an entry level software engineer is per year 15 aug 2015 according to glassdoor, which gathered information from over 15,000 developers, the national developer salary. Filter by location 11 feb 2018 131 entry level software developer salaries provided anonymously employees. Software engineers design, construct and maintain both software systems based on the needs of computer mobile 9 feb 2018 how much does an entry level engineer make in michigan? The average salary for is per year michigan, which meets national. Does it make sense to use the same interview process we'd used for other engineers? How much would. Entry level software developer salary expectations coding dojo. What salary does a software engineer earn in san jose? . Salary estimates are based on 53 salaries submitted anonymously to indeed by entry level software how much does an engineer make in austin, tx? The average salary for is per year tx, which 24view i hourly wages. These engineers spend most of their day writing code to make products and services function. What salary does a entry level software developer earn in your area? . Entry level so
Просмотров: 1 new sparky
The National for Tuesday February 27, 2018 - Federal Budget, Syria, Beer Thief
 
47:12
Welcome to The National, the flagship nightly newscast of CBC News »»» Subscribe to The National to watch more videos here: https://www.youtube.com/user/CBCTheNational?sub_confirmation=1 Voice Your Opinion & Connect With Us Online: The National Updates on Facebook: https://www.facebook.com/thenational The National Updates on Twitter: https://twitter.com/CBCTheNational »»» »»» »»» »»» »»» The National is CBC Television's flagship news program. Airing six days a week, the show delivers news, feature documentaries and analysis from some of Canada's leading journalists.
Просмотров: 8836 CBC News: The National